FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lamotrigine Tablet, Extended Release
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Par Health, Inc. (New 04/29/2026)

Company Contact Information:
800-828-9393

Presentation	Posting Date	Related Information
Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)	04/29/2026	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)	04/29/2026	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)	04/29/2026	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)	04/29/2026	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)	04/29/2026	Discontinuation of the manufacture of the drug
Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)	04/29/2026	Discontinuation of the manufacture of the drug